BioSpace News Archive

Business

Prometheus Laboratories Announces Collaboration with Fresenius Kabi on Anser Testing

Prometheus Laboratories Inc. today announced a collaboration with Fresenius Kabi to support the validation of and access to Anser therapeutic drug monitoring (TDM) services for eligible patients receiving the Fresenius Kabi biosimilar, IDACIO (adalimumab-aacf).

August 1, 2023
·
3 min read
Business

Novavax to Host Conference Call to Discuss Second Quarter 2023 Financial Results and Operational Highlights on August 8, 2023

Novavax, Inc. today announced it will report its second quarter 2023 financial results and operational highlights at 8:30 a.m. Eastern Daylight Time (EDT) on Tuesday, August 8, 2023.

August 1, 2023
·
1 min read
FDA

Francis Medical Receives U.S. FDA Breakthrough Device Designation for Vanquish Minimally Invasive Prostate Cancer Therapy

Francis Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for its Vanquish minimally invasive water vapor ablation therapy.

August 1, 2023
·
3 min read
Deals

SOHM Inc. Signs LOI to Acquire Stem Cell Disruptive Technology and Patents

SOHM, Inc. announces that the company has signed a letter of intent to acquire stem cell disruptive technology and patents called “ABBIE.”

August 1, 2023
·
5 min read
BioForest

AVM Biotechnology Announces Twenty-Eight (28) Solid Tumor and Blood Cancer Patients have been Treated with Immunomodulatory AVM0703 through Expanded Access/Compassionate Use Programs

Dr. Ching-Hon Pui, Co-Leader, Hematological Malignancies Program, St. Jude, Memphis, TN and 2020 American Cancer Society Medal of Honor Awardee, “I am very impressed with your previous efforts to help my former patient.

August 1, 2023
·
9 min read
BioMidwest

AAOS Releases New Guidance to Elevate and Simplify Patient-Reported Outcome Measures in Practice

Patient-reported outcome measures are utilized to improve and assess the quality of care provided by orthopaedic surgeons to their patients.

August 1, 2023
·
4 min read
Awakn Life Sciences Completes Sale of Awakn Clinics In Norway

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”) a clinical-stage biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD)

August 1, 2023
·
5 min read
Pharm Country

Orthoscan Announces End of Life for Orthoscan FD, FD-OR, Mobile DI, and FD Pulse Mini C-Arms

Orthoscan announced the End of Life plan for its Orthoscan FD, FD-OR, Mobile DI, and FD Pulse Mini C-Arms.

August 1, 2023
·
2 min read
Biotech Bay

Gynesonics’ Incision-Free Sonata Procedure for the Treatment of Uterine Fibroids is Now Covered by UnitedHealthcare

Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is please to announce that its Sonata® Procedure is now covered by UnitedHealthcare, effective August 1, 2023.

August 1, 2023
·
3 min read
Pharm Country

Vyera Pharmaceuticals, LLC and Phoenixus AG Sign Asset Purchase Agreement to Sell Rights to Daraprim and Vecamyl

Vyera Pharmaceuticals, LLC and Phoenixus AG announced that they have entered into an Asset Purchase Agreement related to Daraprim and Vecamyl.

August 1, 2023
·
4 min read